Sagimet Biosciences (SGMT) Total Liabilities (2023 - 2024)
Sagimet Biosciences has reported Total Liabilities over the past 2 years, most recently at $4.1 million for Q3 2024.
- Quarterly results put Total Liabilities at $4.1 million for Q3 2024, down 18.97% from a year ago — trailing twelve months through Sep 2024 was $4.1 million (down 18.97% YoY), and the annual figure for FY2023 was $5.7 million, changed.
- Total Liabilities for Q3 2024 was $4.1 million at Sagimet Biosciences, down from $5.7 million in the prior quarter.
- Over the last five years, Total Liabilities for SGMT hit a ceiling of $192.7 million in Q1 2023 and a floor of $4.1 million in Q3 2024.